DealForma Research

Recent Articles

Neurology R&D Partnerships, M&A and Venture Funding by Tech – Q1 2025 Review

June 30, 2025

Neurology R&D Partnerships, M&A and Venture Funding – Q1 2025 Review

June 24, 2025

Cancer R&D Partnerships, M&A and Venture Funding by Tech – Q1 2025 Review

June 13, 2025

Cancer R&D Partnerships, M&A and Venture Funding Activity by TA – Q1 2025

June 10, 2025

MedTech, Device, Digital Health, and Wearables M&A and Ventures – Q1 2025

June 4, 2025

Biopharma Therapeutics and Platforms IPO Activity – Q1 2025 Review

May 22, 2025

Biopharma Therapeutics and Platforms Venture Funding – Q1 2025 Review

May 15, 2025

Biopharma Therapeutics and Platforms M&A Q1 2025

May 8, 2025

Biopharma Therapeutics and Platforms R&D Partnerships Q1 2025

May 8, 2025

Gene Therapy R&D Partnerships, M&A and Ventures in 2024

May 8, 2025

Autoimmune R&D Partnerships, M&A, Ventures, and IPOs in 2024

April 20, 2025

Global Healthcare and Life Sciences – Q1 2025 Review

April 14, 2025

Neurologic R&D Partnerships, M&A, Ventures, and IPOs in 2024

April 14, 2025

All of this by stage, disease indication, modality, target…

+ 0 k

Licensing Deals

+ 0 k

M&A

+ 0 k

Other Deals

+ 0 k

Funding Rounds

+ 0 k

Company Profiles

+ 0 k

Drug Sales Figures